Maverick Simulation Solutions to Invest Rs 500 Mn in R&D
Products

Maverick Simulation Solutions to Invest Rs 500 Mn in R&D

Maverick Simulation Solutions, a leading Indian company that manufactures simulation solutions for medical and nursing training, has announced an investment of Rs 500 million into its research and development division. The investment will be used to enhance product innovation in areas such as Task Trainers, High End Simulators, CPR Trainers, etc. and to integrate advanced technologies like artificial intelligence, augmented reality, and virtual reality into its training solutions. The funds will also support the creation of new prototypes and the strengthening of in-house capabilities across engineering, clinical integration, and content development. The R&D work will be carried out in India, with testing and feedback from academic institutions.
 
Maverick began with 3D scanning and printing services and entered into the medical simulation domain in 2019, with manufacturing of its simulators starting in 2021, with the focus on made in India products. The company develops various medical simulators and works with institutions like AIIMS, DRDO, and IITs. Its mission is to improve healthcare skills and reduce errors through practical training tools.
 
The objective behind this R&D investment is to support better clinical education by developing practical, realistic, re-usable training tools. The company aims to expand its R&D capabilities to meet the growing demand for hands-on training in medical, nursing, and paramedical education. Maverick has crossed a revenue of more than Rs 1 billion in FY 2024-25, reflecting the increasing adoption of its solutions across institutions.
 
Anuj Chahal, Founder & CEO of Maverick Simulation Solutions, said, “The future of healthcare education depends on how well today’s students are trained for real clinical challenges. Our goal is to change how training is delivered. We are not only making tools but also making them accessible to institutions across India. With this R&D investment, we want to improve product design, introduce new technologies like AR and VR, and make training more realistic and repeatable. Our aim is to impact more than 250 institutions and reach Rs 3 billion in revenue in the coming year. This is a step toward building strong foundations in healthcare learning.”
 
Maverick manufactures a wide range of made-in-India medical simulators that are already in use across many renowned medical institutions in the country. Its products include tools for Injection Trainer, Breast Examination Trainer, vascular access, airway management, and catheterisation in low fidelity and LuSi and Test Chest as most advanced simulators currently available in the market. These simulators are used by students and trainers/instructors to practice key procedures in a safe, controlled environment. The company aims to expand access to more institutions, including those in rural and semi-urban areas.
 
Dr. Sunil Tomar, Director at Maverick Simulation Solutions, said, “Simulation-based learning plays an important role in helping students gain clinical confidence. Tools like IV arms and airway management simulators are now a part of the training curriculum. These products help students enhance their motor skills & practice procedures multiple times before working with real patients. Access to such tools is becoming essential for medical education.”
 
With this R&D expansion, Maverick plans to strengthen its presence in the healthcare training market by creating affordable, practical, and locally designed simulation tools. The company will continue working with academic partners to ensure the tools meet real classroom and clinical needs across India.
 
Maverick is focused on expanding access to skill-based training across India. With this R&D push, the company aims to support the growing demand for locally made medical simulators and improve training outcomes.

Pic caption: Anuj Chahal, Founder & CEO of Maverick Simulation Solutions

Maverick Simulation Solutions, a leading Indian company that manufactures simulation solutions for medical and nursing training, has announced an investment of Rs 500 million into its research and development division. The investment will be used to enhance product innovation in areas such as Task Trainers, High End Simulators, CPR Trainers, etc. and to integrate advanced technologies like artificial intelligence, augmented reality, and virtual reality into its training solutions. The funds will also support the creation of new prototypes and the strengthening of in-house capabilities across engineering, clinical integration, and content development. The R&D work will be carried out in India, with testing and feedback from academic institutions. Maverick began with 3D scanning and printing services and entered into the medical simulation domain in 2019, with manufacturing of its simulators starting in 2021, with the focus on made in India products. The company develops various medical simulators and works with institutions like AIIMS, DRDO, and IITs. Its mission is to improve healthcare skills and reduce errors through practical training tools. The objective behind this R&D investment is to support better clinical education by developing practical, realistic, re-usable training tools. The company aims to expand its R&D capabilities to meet the growing demand for hands-on training in medical, nursing, and paramedical education. Maverick has crossed a revenue of more than Rs 1 billion in FY 2024-25, reflecting the increasing adoption of its solutions across institutions. Anuj Chahal, Founder & CEO of Maverick Simulation Solutions, said, “The future of healthcare education depends on how well today’s students are trained for real clinical challenges. Our goal is to change how training is delivered. We are not only making tools but also making them accessible to institutions across India. With this R&D investment, we want to improve product design, introduce new technologies like AR and VR, and make training more realistic and repeatable. Our aim is to impact more than 250 institutions and reach Rs 3 billion in revenue in the coming year. This is a step toward building strong foundations in healthcare learning.” Maverick manufactures a wide range of made-in-India medical simulators that are already in use across many renowned medical institutions in the country. Its products include tools for Injection Trainer, Breast Examination Trainer, vascular access, airway management, and catheterisation in low fidelity and LuSi and Test Chest as most advanced simulators currently available in the market. These simulators are used by students and trainers/instructors to practice key procedures in a safe, controlled environment. The company aims to expand access to more institutions, including those in rural and semi-urban areas. Dr. Sunil Tomar, Director at Maverick Simulation Solutions, said, “Simulation-based learning plays an important role in helping students gain clinical confidence. Tools like IV arms and airway management simulators are now a part of the training curriculum. These products help students enhance their motor skills & practice procedures multiple times before working with real patients. Access to such tools is becoming essential for medical education.” With this R&D expansion, Maverick plans to strengthen its presence in the healthcare training market by creating affordable, practical, and locally designed simulation tools. The company will continue working with academic partners to ensure the tools meet real classroom and clinical needs across India. Maverick is focused on expanding access to skill-based training across India. With this R&D push, the company aims to support the growing demand for locally made medical simulators and improve training outcomes.Pic caption: Anuj Chahal, Founder & CEO of Maverick Simulation Solutions

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code